Imeik Technology Development Co Ltd
SZSE:300896

Watchlist Manager
Imeik Technology Development Co Ltd Logo
Imeik Technology Development Co Ltd
SZSE:300896
Watchlist
Price: 203.91 CNY -0.62% Market Closed
Market Cap: 61.8B CNY
Have any thoughts about
Imeik Technology Development Co Ltd?
Write Note

Gross Margin
Imeik Technology Development Co Ltd

94.1%
Current
94%
Average
63.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
94.1%
=
Gross Profit
2.9B
/
Revenue
3.1B

Gross Margin Across Competitors

Country CN
Market Cap 61.7B CNY
Gross Margin
94%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 310.3B USD
Gross Margin
67%
Country US
Market Cap 141.6B USD
Gross Margin
60%
Country US
Market Cap 115.3B USD
Gross Margin
78%
Country US
Market Cap 102.4B USD
Gross Margin
86%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 134.4B AUD
Gross Margin
52%
Country US
Market Cap 77.3B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 35.8B EUR
Gross Margin
89%
No Stocks Found

Imeik Technology Development Co Ltd
Glance View

Market Cap
61.7B CNY
Industry
Biotechnology

Imeik Technology Development Co Ltd is a prominent player in the cosmetic medical industry, a sector that has experienced robust growth fueled by rising consumer demand for aesthetic enhancements. Situated in the heart of the beauty-conscious market of China, Imeik specializes in the development, manufacturing, and commercialization of medical aesthetic products, most notably hyaluronic acid fillers. These products, used extensively by dermatologists and beauty clinics, cater to individuals seeking non-invasive procedures to enhance their aesthetic appeal. By leveraging advanced biotechnological methodologies, Imeik has positioned itself as a trusted brand, gaining an edge through continual innovation and adherence to rigorous safety standards. The company's business model revolves around the strategic development and distribution of a diversified portfolio of aesthetic products. Imeik's revenue streams principally derive from the commercialization of its cutting-edge dermal fillers and other complementary medical solutions. By focusing on research and development, the company not only stays ahead of aesthetic trends but also ensures that its offerings maintain a high standard of efficacy and safety, essential in a sensitive market domain like medical aesthetics. Furthermore, Imeik’s collaborations with key stakeholders in the healthcare and cosmetic sectors amplify its reach, solidifying its market position and driving sustainable profitability. Through these endeavors, Imeik effectively captures a slice of the lucrative and rapidly growing beauty market, reinforcing its leadership within the industry.

Intrinsic Value
195.23 CNY
Overvaluation 4%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
94.1%
=
Gross Profit
2.9B
/
Revenue
3.1B
What is the Gross Margin of Imeik Technology Development Co Ltd?

Based on Imeik Technology Development Co Ltd's most recent financial statements, the company has Gross Margin of 94.1%.